Maravai LifeSciences Holdings (FRA:MAR) Ending Cash Position : €516.8 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Maravai LifeSciences Holdings Ending Cash Position?

Maravai LifeSciences Holdings's Ending Cash Position for the quarter that ended in Mar. 2024 was €516.8 Mil.

Maravai LifeSciences Holdings's quarterly Ending Cash Position declined from Sep. 2023 (€543.1 Mil) to Dec. 2023 (€527.2 Mil) and declined from Dec. 2023 (€527.2 Mil) to Mar. 2024 (€516.8 Mil).

Maravai LifeSciences Holdings's annual Ending Cash Position increased from Dec. 2021 (€487.9 Mil) to Dec. 2022 (€596.7 Mil) but then declined from Dec. 2022 (€596.7 Mil) to Dec. 2023 (€527.2 Mil).

Maravai LifeSciences Holdings Ending Cash Position Historical Data

The historical data trend for Maravai LifeSciences Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maravai LifeSciences Holdings Ending Cash Position Chart

Maravai LifeSciences Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

22.23

194.14

487.88

596.74

527.24

Maravai LifeSciences Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															586.81	535.50	543.09	527.24	516.76

Maravai LifeSciences Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Maravai LifeSciences Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	579.671	+	-52.431
	=	527.2

Maravai LifeSciences Holdings's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	528.965	+	-12.209
	=	516.8

Maravai LifeSciences Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Maravai LifeSciences Holdings (FRA:MAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (FRA:MAR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MRVI:USA MRVI:Mexico MAR:Germany

Address

10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121

Website

https://www.maravai.com

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.